Vitamin E does not reduce the side‐effects of isotretinoin in the treatment of acne vulgaris
Authors:
- 22 March 2004
- journal article
- clinical trial
- Published by Wiley in International Journal of Dermatology
- Vol. 44 (3) , 248-251
Abstract
Background Isotretinoin is widely used in the treatment of severe, recalcitrant, nodular acne. Mucocutaneous side‐effects are seen in the great majority of patients and some of them have elevations in their serum lipid and liver enzyme profiles. Recently, it has been shown that addition of vitamin E decreased the toxicity of high‐dose retinoids.Objective The purpose of this investigator‐blinded, randomized study was to assess whether vitamin E would reduce the side‐effects of isotretinoin in the treatment of acne vulgaris.Methods Eighty two patients were randomly assigned to one of two treatment groups with isotretinoin (1 mg/kg/day) alone or combined with vitamin E (800 IU/day). The treatment duration was 16 weeks. Mucocutaneous side‐effects such as facial erythema, facial dryness, cheilitis and serum lipid and liver enzyme profiles were assessed.Results There was no difference in the incidence and severity of side‐effects related to isotretinoin between the two treatment groups.Conclusion Eight hundred IU/day vitamin E did not improve the side‐effects of 1 mg/kg/day of isotretinoin in the treatment of acne vulgaris.Keywords
This publication has 11 references indexed in Scilit:
- Uses and complications of isotretinoin therapyJournal of the American Academy of Dermatology, 2001
- Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: A randomized trialJournal of the American Academy of Dermatology, 2000
- A Phase II Trial of Isotretinoin and Alpha Interferon in Patients With Recurrent Squamous Cell Carcinoma of the CervixAmerican Journal of Clinical Oncology, 1998
- Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicityAnnals of Oncology, 1997
- Roaccutane Treatment Guidelines: Results of an International SurveyDermatology, 1997
- Long-term safety of isotretinoin as a treatment for acne vulgarisBritish Journal of Dermatology, 1994
- Side effects of systemic retinoids and their clinical managementJournal of the American Academy of Dermatology, 1992
- Guidelines for optimal use of isotretinoin in acneJournal of the American Academy of Dermatology, 1992
- Report of the consensus conference on acne classificationJournal of the American Academy of Dermatology, 1991
- Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherolThe American Journal of Medicine, 1990